2,5-substituted oxazolopyrimidine derivatives

Details for Australian Patent Application No. 2011206617 (hide)

Owner Sanofi

Inventors Kadereit, Dieter; Schaefer, Matthias; Hachtel, Stephanie; Dietrich, Axel; Huebschle, Thomas; Hiss, Katrin

Agent Watermark

Pub. Number AU-A-2011206617

PCT Pub. Number WO2011/086081

Priority 10305044.9 14.01.10 EP

Filing date 12 January 2011

Wipo publication date 21 July 2011

International Classifications

C07D 498/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/519 - ortho- or peri-condensed with heterocyclic rings

A61P 9/00 Drugs for disorders of the cardiovascular system

Event Publications

2 August 2012 PCT application entered the National Phase

  PCT publication WO2011/086081 Priority application(s): WO2011/086081

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011206621-Thiazole and oxazole kinase inhibitors

2011206616-Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring